![Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline - Practical Radiation Oncology Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline - Practical Radiation Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/af3f8eb5-b743-4c0c-8ef7-5dcd47c1abf9/gr1_lrg.jpg)
Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline - Practical Radiation Oncology
![Detection and characterization of lung cancer using cell-free DNA fragmentomes | Nature Communications Detection and characterization of lung cancer using cell-free DNA fragmentomes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24994-w/MediaObjects/41467_2021_24994_Fig1_HTML.png)
Detection and characterization of lung cancer using cell-free DNA fragmentomes | Nature Communications
![Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0938b60e-81f4-41d5-b76f-c757c9f407c5/gr1.jpg)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Therapy-Related Acute Myelogenous Leukemia With an 11q23/MLL Translocation Following Adjuvant Cisplatin and Vinorelbine for Non–Small-Cell Lung Cancer - Clinical Lung Cancer Therapy-Related Acute Myelogenous Leukemia With an 11q23/MLL Translocation Following Adjuvant Cisplatin and Vinorelbine for Non–Small-Cell Lung Cancer - Clinical Lung Cancer](https://www.clinical-lung-cancer.com/pb/assets/raw/Health%20Advance/journals/cllc/logo.gif)
Therapy-Related Acute Myelogenous Leukemia With an 11q23/MLL Translocation Following Adjuvant Cisplatin and Vinorelbine for Non–Small-Cell Lung Cancer - Clinical Lung Cancer
PLOS ONE: Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data
![Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3a7f842d-3d5e-45df-bb55-6ff82add44dd/gr1_lrg.jpg)
Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial - eClinicalMedicine
![PDF) Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (MYSTIC) PDF) Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (MYSTIC)](https://i1.rgstatic.net/publication/349490021_Patient-Reported_Outcomes_with_Durvalumab_With_or_Without_Tremelimumab_Versus_Standard_Chemotherapy_as_First-Line_Treatment_of_Metastatic_Non-Small_Cell_Lung_Cancer_MYSTIC/links/609887fca6fdccaebd1d787d/largepreview.png)
PDF) Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (MYSTIC)
![Clinical Impact of High-Throughput Gene Expression Studies in Lung Cancer - Journal of Thoracic Oncology Clinical Impact of High-Throughput Gene Expression Studies in Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040021309/2053563497/gr1.jpg)